Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity


Phase 3 Results

Summary of Purpose

This is a study to confirm the superior efficacy of a single treatment of GSK1358820 over placebo in patients with post-stroke upper limb spasticity of both the wrist and finger flexors using the Modified Ashworth Scale (MAS) wrist score.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 May 2017.

1 May 2007 13 Apr 2007 1 Dec 2008 1 Dec 2008 1 May 2017 2 Sep 2009
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available